Alembic Pharmaceuticals informs about receipt of USFDA final approval

15 Jan 2020 Evaluate

Alembic Pharmaceuticals has informed that the Company has received US Food & Drug Administration (USFDA) Final Approval for Tizanidine Hydrochloride Capsules, 2 mg, 4 mg, and 6 mg. 

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

969.00 -3.70 (-0.38%)
16-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1532.20
Dr. Reddys Lab 5820.00
Cipla 1423.85
Zydus Lifesciences 1008.15
Lupin 1659.15
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.